What's next for Ebos after the end of that Chemist Warehouse contract

What's next for Ebos after the end of that Chemist Warehouse contract
CEO John Cullity says there isn't double-digit growth to be found in animal or healthcare in Australasia. (Image: Ebos)
Rebecca Stevenson
Ebos chief executive John Cullity says the firm must hunt outside of Australasia for double-digit growth. The dual-listed healthcare and pharmaceutical marketer and wholesaler was looking for growth outside its traditional powerhouse pharmaceutical business, Cullity said. He said Ebos’s pharmacy business in NZ and Australia was solid and stable but had relatively low growth. “Double-digit growth rates are going to be very hard, so we need to broaden the group's base of earnings outside of Australia and New Zealand...

More Markets

NZ sharemarket rises ahead of interest rate decision
Markets Market close

NZ sharemarket rises ahead of interest rate decision

The S&P/NZX 50 Index closed at 12,765.24, up 28.18 points or 0.22%.

IkeGPS revenue shows sparks for subscriptions play
Markets

IkeGPS revenue shows sparks for subscriptions play

Despite a $7m net loss, subscription revenue grew 28%.

Ben Moore 12:00pm
My Food Bag profitability up, customer numbers dip
Retail

My Food Bag profitability up, customer numbers dip

Company expects market conditions to remain challenging in the second half.

Aft takes $6.5m hit on doctor strike and destocking
Markets

Aft takes $6.5m hit on doctor strike and destocking

Income in international markets affected by two events.